Ursprung des Netzwerks ersten Grades von Go Sato
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Fast Track Initiative, Inc.
 Fast Track Initiative, Inc. Investment ManagersFinance Fast Track Initiative, Inc. (FTI) is a Venture Capital firm, a subsidiary of Life Science Management, Inc. founded in 2004 by Koichi Ashida and Hiromichi Kimura. Fast Track Initiative, Inc. is headquartered in Tokyo with additional office in the Unites States.
4
| Subsidiary | Investment Managers | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Go Sato
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
HanaVax, Inc.
 HanaVax, Inc. BiotechnologyHealth Technology HanaVax, Inc. develops nasal vaccine against infectious diseases. It develops pneumococcal nasal vaccine to prevent pneumonia, sepsis and otitis media. The company was founded by Hosei Ou on December 27, 2017 and is headquartered in Tokyo, Japan. | Biotechnology | Director/Board Member | |
Rin Institute, Inc.
 Rin Institute, Inc. Pharmaceuticals: MajorHealth Technology Rin Institute, Inc. is a company based in Tokyo, Japan that was founded in 2016 by Kentaro Yoshimatsu. The Japanese company's website simply states that it is "just another WordPress site." | Pharmaceuticals: Major | Director/Board Member | |
Sonire Therapeutics, Inc. (TY)
 Sonire Therapeutics, Inc. (TY) Medical SpecialtiesHealth Technology Sonire Therapeutics, Inc. (TY) is a company based in Tokyo, Japan. The Japanese company specializes in developing a next-generation ultrasonic guide ultrasonic ultrasonic treatment device using acoustic engineering (ultrasonic) technology created from academia, which conducts cutting-edge research. The device uses high-intensity focused ultrasound (HIFU) and is designed to be used under ultrasonic guidance. The company was founded in 2020 and the CEO is Toru Sato. | Medical Specialties | Director/Board Member |
Statistik
International
| Japan | 4 |
Sektoral
| Health Technology | 4 |
Operativ
| Director/Board Member | 3 |
| Private Equity Investor | 2 |
| Corporate Officer/Principal | 1 |
| Private Equity Analyst | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Hiroko Kimura | 3 |
| Hajime Okuyama | 2 |
| Kazuhiko Takeshige | 1 |
| Asaka Itoh | 1 |
